Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection
A Microsimulation Study
- Epstein, Rachel L
- Munroe, Sarah
- Taylor, Lynn E
- Duryea, Patrick R
- Buzzee, Benjamin
- Pramanick, Tannishtha
- Feld, Jordan J
- Baptiste, Dimitri
- Carroll, Matthew
- Castera, Laurent
- Sterling, Richard K
- Thomas, Aurielle
- Chan, Philip A
- Linas, Benjamin P
Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA
Department of Pediatrics, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, Rhode Island, USA
Department of Primary Care, HealthFirst Family Care Center Inc., Fall River, Massachusetts, USA
Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, Rhode Island, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Department of Hepatology, Beaujon Hospital, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Clichy, France
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA
Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, Rhode Island, USA
Rhode Island Department of Health, Providence, Rhode Island, USA
Department of Medicine, Brown University, Providence, Rhode Island, USA
Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA
Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA
Current affiliation: University of Nebraska-Lincoln, Department of Psychology, Lincoln, Nebraska, USA.
Current affiliation: Department of Healthcare Policy, Harvard Medical School, Cambridge, Massachusetts, USA.
Current affiliation: The Miriam Hospital, Providence, Rhode Island, USA.
Correspondence: R. L. Epstein, Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, 801 Massachusetts Avenue, Crosstown Center 2nd Flr, Boston, MA 02118 ([email protected]); S. Munroe, Section of Infectious Diseases, Boston Medical Center, 801 Massachusetts Avenue, Crosstown Center 2nd Flr, Boston, MA 02118 ([email protected]).
Potential conflicts of interest. Research grants to institution unrelated to this study: R. K. S.—Gilead, AbbVie, Abbott, Roche, and Zydus; J. J. F.—Abbvie, Cepheid and Gilead. Consulting fees unrelated to this study: J. J. F.—Abbvie and Gilead; L. C.—Boston pharmaceutical, Echosens, Gilead, GSK, Madrigal, MSD, Novo Nordisk, Pfizer, Sagimet and Siemens Healthineers. L. C. received speaker fees unrelated to this project from Echosens, Gilead, Inventiva, Madrigal and Novo Nordisk. All other authors report no potential conflicts.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Received June 03, 2024
Revised November 13, 2024
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
